Position in GILD
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$1,002,507
-$275,655 QoQ
Shares Held
7,935
-13.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,065
of 2,266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 66%
Shared 0%
None 34%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026180 WEALTH ADVISORS, LLC holds $30,472,982 across 12 Drug Manufacturers - General names. GILD ranks #9 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
44,833 | $5,761,040 | |
| 2 | AMGN |
Amgen Inc
|
15,157 | $5,488,652 | |
| 3 | AZN |
Astrazeneca PLC
|
20,498 | $3,886,830 | |
| 4 | JNJ |
Johnson & Johnson
|
12,751 | $3,238,371 | |
| 5 | OGN |
Organon & Co.
|
226,383 | $3,065,225 | |
| 6 | LLY |
ELI LILLY & Co
|
2,524 | $3,027,361 | |
| 7 | ABBV |
AbbVie Inc.
|
6,433 | $1,618,800 | |
| 8 | PFE |
Pfizer Inc
|
47,953 | $1,154,708 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,002,507 | 7,935 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $1,278,162 | 9,171 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,107,114 | 9,020 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $1,091,463 | 9,833 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $1,373,346 | 12,387 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,228,068 | 10,960 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $1,015,146 | 10,990 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $508,908 | 6,070 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $423,392 | 6,171 | Shares | Sole | 2024-07-16 | |
| No filing history on record for this holder in this stock. | ||||||